WEBULL
News
OPK
1.150
-4.17%
-0.050
Weekly Report: what happened at OPK last week (0216-0220)?
Weekly Report · 15h ago
Earnings week ahead: NVDA, CRM, HD, BIDU, LOW, DELL, SNOW, AMC, ZM, and more
Seeking Alpha · 1d ago
Weekly Report: what happened at OPK last week (0209-0213)?
Weekly Report · 02/16 10:28
Opko Health Inc. to Report Fourth Quarter and Full-Year 2025 Financial Results
Reuters · 02/12 13:00
Opko Health: Expanding Pipeline and Strategic Partnerships Underpin Buy Rating and Long-Term Value Upside
TipRanks · 02/09 13:45
Weekly Report: what happened at OPK last week (0202-0206)?
Weekly Report · 02/09 10:29
Opko Health Entera Bio, Entera Bio expand partnership to advance PTH tablet
TipRanks · 02/04 13:16
OPKO Health Expands Partnership With Entera Bio To Advance First-in-Class Oral Long Acting PTH Tablet
Benzinga · 02/04 13:05
OPKO HEALTH AND ENTERA BIO EXPAND PARTNERSHIP TO ADVANCE FIRST-IN-CLASS ORAL LONG ACTING PTH TABLET FOR PATIENTS WITH HYPOPARATHYROIDISM
Reuters · 02/04 13:05
Steve Rubin Joins Entera Bio Board as Gerry Ostrov Steps Down
Reuters · 02/04 13:00
Steve Rubin wird neues Vorstandsmitglied bei Entera Bio Ltd
Reuters · 02/04 13:00
Steve Rubin Joins Entera Bio Board as OPKO Health Expands Partnership
Reuters · 02/04 13:00
Weekly Report: what happened at OPK last week (0126-0130)?
Weekly Report · 02/02 10:29
OPKO Health: Deeply Mispriced Ahead Of Major Catalysts
Seeking Alpha · 01/27 09:03
Weekly Report: what happened at OPK last week (0119-0123)?
Weekly Report · 01/26 10:29
Analysts Are Bullish on Top Healthcare Stocks: Opko Health (OPK), Achieve Life Sciences (ACHV)
TipRanks · 01/21 16:30
Weekly Report: what happened at OPK last week (0112-0116)?
Weekly Report · 01/19 10:36
A Look At OPKO Health (OPK) Valuation As Shares Trade Around US$1.30
Simply Wall St · 01/15 05:32
OrthoPediatrics (KIDS) Moves 9.8% Higher: Will This Strength Last?
NASDAQ · 01/13 09:43
Weekly Report: what happened at OPK last week (0105-0109)?
Weekly Report · 01/12 10:35
More
Webull provides a variety of real-time OPK stock news. You can receive the latest news about Opko Health through multiple platforms. This information may help you make smarter investment decisions.
About OPK
OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company’s segments include pharmaceutical and diagnostics. The pharmaceutical segment consists of the pharmaceutical operations it operates in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its global pharmaceutical research and development operations. The diagnostics segment primarily consists of clinical laboratory operations through BioReference and its point-of-care operations. Its pharmaceutical business features Somatrogon (hGH-CTP), a once-weekly human growth hormone injection, and it is marketed under the brand name NGENLA. The Company, through its pharmaceutical division, manufactures and sells Rayaldee, a United States Food and Drug Administration (FDA) approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.